Public health guidance on HIV, hepatitis B and C testing in the EU/EEA
This guidance aims to provide EU/EEA countries with an evidence-based framework to help develop, implement, monitor and evaluate their own national HBV, HCV and HIV testing guidelines and programmes.
Accessibility and acceptability of infectious disease interventions among migrants in the eu/eea: A cerqual systematic review
Driedger, M., Mayhew, A., Welch, V., Agbata, E., Gruner, D., Greenaway, C., Noori, T., Sandu, M., Sangou, T., Mathew, C., Kaur, H., Pareek, M., Pottie, K.
The effectiveness and cost-effectiveness of hepatitis c screening for migrants in the EU/EEA: A systematic review
Greenaway, C., Makarenko, I., Chakra, C.N.A., Alabdulkarim, B., Christensen, R., Palayew, A., Tran, A., Staub, L., Pareek, M., Meerpohl, J.J., Noori, T., Veldhuijzen, I., Pottie, K., Castelli, F., Morton, R.L.
Hepatitis B and C testing activities, needs, and priorities in the EU/EEA
ECDC undertook a survey to assess needs and priorities prior to developing guidance on testing and screening for hepatitis B and C (HBV/HCV) in the EU/EEA, and to update the existing evidence on the burden of HBV/HCV morbidity and mortality across EU/EEA Member States.
Epidemiological assessment of hepatitis B and C among migrants in the EU/EEA
This report gives an overview of chronic hepatitis B and C virus infection among foreign-born migrants in the EU/EEA.
Assessing the burden of key infectious diseases affecting migrant populations in the EU/EEA
This report presents the main findings of an ECDC project to assess the burden of infectious diseases among migrants in the EU/EEA based on available data for specific diseases: human immunodeficiency virus (HIV), tuberculosis (TB), hepatitis B, hepatitis C, gonorrhoea, syphilis, measles and rubella, malaria and Chagas disease.
Assessing the burden of key infectious diseases affecting migrant populations in the EU/EEA: Executive summary
ECDC and EMCDDA technical guidance on prevention and control of infectious diseases among people who inject drugs
The content of this joint guidance was developed by the European Centre for Disease Prevention and Control (ECDC) and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) with the support of a technical advisory group composed of policy makers, service providers, civil society representatives and preventative health experts from throughout the EU/EEA.
ECDC and EMCDDA technical guidance on prevention and control of infectious diseases among people who inject drugs - guidance in brief
This evidence-based guidance is designed to inform the development, monitoring and evaluation of national strategies and programmes in countries in Europe in order to reduce and prevent infections among people who inject drugs.
Hepatitis B and C in the EU neighbourhood: prevalence, burden of disease and screening policies
This literature review answers a series of questions on the prevalence of chronic HBV and HCV infection in the general EU population, the number of individuals with chronic HBV or HCV infection, and current national practices for screening for chronic HBV and HCV infection, all with the overarching goal of promoting national and European policies on the secondary prevention of these two diseases.